BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29099287)

  • 1. PAX5 gene as a novel methylation marker that predicts both clinical outcome and cisplatin sensitivity in esophageal squamous cell carcinoma.
    Kurimoto K; Hayashi M; Guerrero-Preston R; Koike M; Kanda M; Hirabayashi S; Tanabe H; Takano N; Iwata N; Niwa Y; Takami H; Kobayashi D; Tanaka C; Yamada S; Nakayama G; Sugimoto H; Fujii T; Fujiwara M; Kodera Y
    Epigenetics; 2017; 12(10):865-874. PubMed ID: 29099287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity.
    Zhang W; Yan W; Qian N; Han Q; Zhang W; Dai G
    Chin Med J (Engl); 2022 Feb; 135(5):606-618. PubMed ID: 35191417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paired box 5 methylation detection by droplet digital PCR for ultra-sensitive deep surgical margins analysis of head and neck squamous cell carcinoma.
    Hayashi M; Guerrero-Preston R; Sidransky D; Koch WM
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1017-26. PubMed ID: 26304463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
    Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
    Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherens junctions associated protein 1 serves as a predictor of recurrence of squamous cell carcinoma of the esophagus.
    Tanaka H; Kanda M; Koike M; Iwata N; Shimizu D; Ezaka K; Sueoka S; Tanaka Y; Takami H; Hashimoto R; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
    Int J Oncol; 2015 Nov; 47(5):1811-8. PubMed ID: 26397940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation.
    Dong SW; Cui YT; Zhong RR; Liang DC; Liu YM; Wang YG; He Z; Wang S; Liang SJ; Zhang P
    Clin Lab; 2012; 58(1-2):41-51. PubMed ID: 22372344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Esophageal Squamous Cell Carcinoma (ESCC) Cells.
    Chen C; Ma Z; Zhang H; Liu X; Yu Z
    Med Sci Monit; 2017 Jul; 23():3353-3359. PubMed ID: 28694421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients.
    Kuo IY; Chang JM; Jiang SS; Chen CH; Chang IS; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
    Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
    Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF5 methylation is a sensitivity marker of esophageal squamous cell carcinoma to definitive chemoradiotherapy.
    Iwabu J; Yamashita S; Takeshima H; Kishino T; Takahashi T; Oda I; Koyanagi K; Igaki H; Tachimori Y; Daiko H; Nakazato H; Nishiyama K; Lee YC; Hanazaki K; Ushijima T
    Sci Rep; 2019 Sep; 9(1):13347. PubMed ID: 31527639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma.
    Yue D; Fan Q; Chen X; Li F; Wang L; Huang L; Dong W; Chen X; Zhang Z; Liu J; Wang F; Wang M; Zhang B; Zhang Y
    Exp Cell Res; 2014 Mar; 322(1):149-58. PubMed ID: 24269829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINE-1 hypomethylation is associated with a poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
    Iwagami S; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Sakamaki K; Ohashi Y; Baba H
    Ann Surg; 2013 Mar; 257(3):449-55. PubMed ID: 23023202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copine 5 expression predicts prognosis following curative resection of esophageal squamous cell carcinoma.
    Umeda S; Kanda M; Koike M; Tanaka H; Miwa T; Tanaka C; Kobayashi D; Suenaga M; Hayashi M; Yamada S; Nakayama G; Kodera Y
    Oncol Rep; 2018 Dec; 40(6):3772-3780. PubMed ID: 30272363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of long non-coding RNA AFAP1-AS1 predicts chemoradioresistance and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
    Zhou XL; Wang WW; Zhu WG; Yu CH; Tao GZ; Wu QQ; Song YQ; Pan P; Tong YS
    Mol Carcinog; 2016 Dec; 55(12):2095-2105. PubMed ID: 26756568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of MDR1 associated with Line-1 hypomethylation in esophageal squamous cell carcinoma.
    Zhu J; Ling Y; Xu Y; Lu MZ; Liu YP; Zhang CS
    Int J Clin Exp Pathol; 2015; 8(11):14392-400. PubMed ID: 26823755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma.
    Du Z; Ma K; Sun X; Li A; Wang H; Zhang L; Lin F; Feng X; Song J
    World J Surg Oncol; 2015 Apr; 13():141. PubMed ID: 25886188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DCC promoter hypermethylation in esophageal squamous cell carcinoma.
    Park HL; Kim MS; Yamashita K; Westra W; Carvalho AL; Lee J; Jiang WW; Baek JH; Liu J; Osada M; Moon CS; Califano JA; Mori M; Sidransky D
    Int J Cancer; 2008 Jun; 122(11):2498-502. PubMed ID: 18302152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
    Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
    Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-terminal binding protein‑2 mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis.
    Shi H; Mao Y; Ju Q; Wu Y; Bai W; Wang P; Zhang Y; Jiang M
    Int J Oncol; 2018 Jul; 53(1):167-176. PubMed ID: 29658564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
    Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
    Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.